LinkedIn image ad examples

Private hospitals are hitting a Net Promoter Score (NPS) of 96. Is yours one of them? Compare your performance against providers worldwide in our 2026 Private Healthcare Industry Benchmarking Report.

Nach der vollständigen Heilung wird die Inspire Therapie aktiviert und individuell angepasst. Dies passiert mit ärztlichen Anweisungen und absprachen. Jürgen H. hat von seinem behandelnden Arzt eine umfassende Einführung erhalten und konnte danach die Stimulation des Zungenschrittmachers über eine Fernbedienung selbstständig nach seinen Bedürfnissen anpassen. Die Anpassung der Stimulation erfolgt schrittweise, bis das System optimal auf die Bedürfnisse eingestellt ist. Nach rund 3 Monaten wurden die Einstellungen im Schlaflabor nochmals feinjustiert. __ Dieser Erfahrungsbericht über die Behandlung der Schlafapnoe bezieht sich auf individuelle Behandlungsergebnisse. Die Aussagen sind echt, repräsentativ und dokumentiert. Der Inspire Nutzer erhielt Reisekostenerstattungen und Aufwandsentschädigungen für den Zeitaufwand im Zusammenhang mit dem Erfahrungsbericht. Diese Informationen sind nur für den professionellen Gebrauch bestimmt. Für Patienten mit mittelschwerer bis schwerer Schlafapnoe bei medizinischer Eignung. Weitere Informationen unter https://lnkd.in/eY8bDQJB.

Over the past days at ERS 2026 in Barcelona, we’ve had the opportunity to connect with healthcare professionals, researchers, patient organisations and partners from around the world at ERS 2026. During discussions on asthma, COPD, bronchiectasis, interstitial lung diseases and sustainable respiratory care, one message stood out: improving respiratory health requires continued collaboration and innovation to create better outcomes for patients. Thank you to everyone who engaged with us, challenged our thinking and shared their perspectives. While ERS 2026 has come to an end, the conversations and learnings will continue to inspire our work in respiratory health.

The climate crisis is a health crisis, and one of the defining conversations in respiratory care, as reflected at ERS 2026. Climate change is worsening respiratory disease and the burden is not felt equally. The most vulnerable communities breathe dirtier air, face longer allergy seasons and often lack access to early diagnosis, meaning symptoms go undetected and conditions deteriorate. At Chiesi, we believe that protecting people’s health also means protecting the environment they live in. That is why we’re committed to Net Zero by 2035, 15 years ahead of the European Climate Neutrality target, with these targets validated by the Science Based Targets Initiative (SBTi).

🍂 Der Herbst kommt – und damit auch die Viren-Saison: Die Hauptursache für schwere Atemwegsinfekte und Krankenhausaufenthalte bei Säuglingen ist eine Erkrankung am Respiratorischen Synzytial-Virus (#RSV). Fast alle Kinder machen in ihren ersten zwei Jahren eine RSV-Infektion durch und 70 % der hospitalisierten Kinder sind gesunde, reifgeborene Babys! 👶 Gründe, warum #Hebamme Christina Kulle, Leiterin der Landesgeschäftsstelle #Kärnten des Österreichischen Hebammengremiums jungen Eltern empfiehlt, ihre Neugeborenen zu schützen – wie sie in der neuen Episode vom Podcast „Am Mikro | skop“ erklärt. 🎙️ Das ganze Gespräch mit ihr, Anna Scheuchenegger, Fachärztin an der Neonatologie auf der Medizinische Universität Graz und am LKH-Univ. Klinikum Graz und Martina Rupp kann hier: https://lnkd.in/dRunYgrc angehört werden – oder überall wo es Podcasts gibt. #InnovativeTherapien #Sanofi #RespiratorischeSyncytialvirus #Schutz #Immunisierung

Participate to our ISPE workshop at CARBOGEN AMCIS in Bubendorf focused on the safe handling of highly active substances. The workshop will combine practical industry experience with discussions around containment, risk assessment and occupational safety, including a tour of our bioconjugation facility. ➡️Register now: https://lnkd.in/eib6S5yu

A major step forward for brain-computer interfaces. 🧠 ABILITY Neurotech has reached an important milestone: for the first time, its BCI system has successfully recorded human neural signals. Conducted during brain tumor surgery at the Technical University of Munich University Hospital Rechts der Isar, this first-in-human testing marks an important step towards clinical application. The technology aims to help restore communication, movement and autonomy for people living with paralysis and speech loss. Based at Campus Biotech and supported by Wyss Geneva, ABILITY Neurotech is moving one step closer to bringing its technology to patients. 👉 Read more about: https://lnkd.in/e8TS_vjS 📸 © Wyss Geneva / ABILITY Neurotech #campusbiotech #abilityneurotech #BCI #neurotechnology #neuroscience #brainhealth #innovation

Als Financieel Medewerker draag je bij aan een organisatie die gedoneerd menselijk weefsel beschikbaar maakt voor transplantatie. Samen met collega’s zorg je voor financiële administratie en heldere financiële overzichten. Solliciteer en maak impact.

Wij zoeken iemand met: 📚 een afgeronde financiële hbo-opleiding. 📈 relevante ervaring binnen financiële administratie. 💻 ruime ervaring met AFAS en goede kennis van Excel. 🤝 hoge mate van integriteit. 👉 Solliciteer als Financieel Medewerker

What happens when you take a GPCR assay out of a recombinant system and into endogenous tissue? Most cAMP pharmacology is generated in recombinant cells overexpressing the receptor. These systems are ideal for screening, but receptor overexpression, receptor reserve and a non-native signalling environment can shift both apparent potency and efficacy. Using TR-FRET, we measured PTH(1-34)-stimulated cAMP accumulation directly in washed membrane preparations from rat kidney and pancreas. In kidney, PTH produced a concentration-dependent response reaching approximately 50% of the forskolin maximum, with a log EC50 of -7.32 (48 nM). A smaller but clear concentration-dependent response was also detected in pancreas, with a log EC50 of -6.99 (102 nM). The important difference is that the receptor is present at its endogenous expression level, within its native tissue membrane and coupled to endogenous Gs and adenylyl cyclase. That gives us a direct way of asking whether pharmacology observed in an engineered system is maintained when the same receptor is studied in a native tissue membrane environment. This is particularly relevant for PTH1R, where cAMP signalling remains central to both established and emerging therapeutics, from teriparatide and abaloparatide in osteoporosis to palopegteriparatide in hypoparathyroidism and oral small-molecule PTH1R agonists now entering clinical development. If you want to understand how your compounds behave in an endogenous system, get in touch. #GPCR #Pharmacology #cAMP #DrugDiscovery #ReceptorPharmacology #Biotechnology #Biotech #Pharma #LifeSciences #ReceptorPharmacology #cAMP #GPCRSignalling #MolecularPharmacology #TranslationalScience #DrugDevelopment #PreclinicalDevelopment #AssayDevelopment #InVitroPharmacology #EndogenousReceptors #PTH1R

A gene therapy is paid for once. The doubt about it can last much longer. The first EU Joint Clinical Assessment for a gene therapy has been published. It covered Onasemnogene abeparvovec intrathecal (Itvisma) for 5q spinal muscular atrophy. The Health Technology Developer argued the therapy was comparable to nusinersen and risdiplam on the basis of non-significant differences in indirect comparisons. The assessors rejected that framing, and picked apart the methodology on three further grounds. Why unresolved comparability hits harder for a single-administration therapy than a chronic one, what the assessors specifically said, and how the ruling reached national reimbursement in Ireland before the JCA was even published, all on the GPI website. https://lnkd.in/dpA5xwFH #HTA #JointClinicalAssessment #GeneTherapy #RareDisease #GPI

🔬 Bluetongue virus continues to spread across European livestock, putting sheep, cattle, and goat herds under increasing pressure. For diagnostic laboratories and veterinary professionals, rapid and reliable screening is an essential requirement to ensure biosecurity and global trade. The DIA-Check Bluetongue ELISA Test is built for exactly this scenario: ⏱️ Results in 90 minutes ✅ No grey zone: clear, actionable interpretation 🧪 No sample predilution required 🔎 Validated across hundreds of samples, multiple laboratories, operators and instruments Designed for rapid serological identification of infected animals, infection-surveillance programs, and the certification of freedom from infection prior to movement. Robust diagnostics designed to help veterinary authorities detect infection early and support surveillance where it matters most. 🔗 Discover the kit #Bluetongue #BTV #VeterinaryDiagnostics #ELISA #AnimalHealth #LivestockHealth #Diatheva

From professional clinicians to expert customer service and community health workers, people find their roles at Friend Health uniquely fulfilling. Think about what you want in your next career move, explore our open roles, and apply to the position that best suits your experience and skills. https://lnkd.in/e5PT-6bt

Radiologists already have the images. Neuroreader® helps make them quantitative. From compatible 3D T1 MRI, Neuroreader® automatically generates quantitative brain structure measurements and statistical information for physician review. Give radiologists another layer of objective information alongside conventional image interpretation.

🌍 Foot-and-Mouth Disease remains one of the most economically devastating livestock diseases worldwide. Diatheva provides the advanced #diagnostic tools required for high-specificity differentiation between naturally infected and vaccinated animals. 🧪 The DIA-Check FMDV NSP ELISA Test targets NSP-3ABC antibodies in cattle, pigs, sheep and goats, offering a robust solution for rapid serological identification and the demonstration of "freedom from infection" status. Product highlights: ✅ No grey zone: Easy interpretation of results 🔬 Validation: Verified on Pirbright sera panel ⏱️ Faster than any other on the market: Results in 100 minutes 🧫 Direct sample testing: No sample predilution required Reliable DIVA diagnostics strengthen disease surveillance, supporting animal health, biosecurity and One Health objectives. 🔗 Discover the kit #FMD #FootAndMouthDisease #VeterinaryDiagnostics #ELISA #LivestockHealth #AnimalTrade #Diatheva

Less than two weeks to go until CAP 2026! US labs are facing increasing diagnostic pressure, with open positions, leave, and rising caseloads putting quality and turnaround times at risk. Visit Diagnexia at Booth 246 to see how virtual primary diagnosis delivers coverage when your group needs it: account-approved pathologists licensed in your state, reading through your existing workflow. Meet the team attending: Dan Kelly, Grant Carlson, Christian Cerbino, Ashley Dull and Ciara Durnin White. Book a meeting in advance: https://lnkd.in/ee_heBiT We can’t wait to connect with you. #Diagnexia #DigitalPathology #Pathology #CAP2026

Manual segmentation of brain structures can require significant physician time and specialized expertise. Neuroreader® automates brain volumetric analysis, quantifying 83 brain volumes in less than 10 minutes from compatible MRI. Give clinical teams objective quantitative information without requiring manual tracing of individual brain structures.

Engage with a group of biopharma analytics experts and hear about: - The emerging trends in analytical intelligence - The role of data science - How to unlock greater value from your analytical data Join us for an expert roundtable event in Basel, 13th October 2026. You can expect: - Hearing expert speakers from CLADE - Participate in discussions around bioanalytics innovation - Network with other biopharma analytics experts Register today 👇

Engage with biopharma analytics experts in-person to learn: - How to unlock greater value from your analytical data - The emerging trends in analytical intelligence - The role of data science Join us for a roundtable event in Basel, 13th October 2026. You can expect: - Hearing from expert speakers from CLADE - Participating in discussions around bioanalytical workflow innovation - Network with other biopharma analytics experts Register today 👇

As the nation's first Virtual Intensive Outpatient Program for eating disorders, Eating Recovery At Home has provided intensive, specialized eating disorder treatment virtually for 10 years. Now available to individuals in New Jersey, our established program brings evidence-based care delivered by experienced clinicians into the home. Learn more about when to refer to a higher level of care.

Pfizer on GPI cost of treatment data. See what it returns on your own markets, at no charge for the evaluation period.

Approvals stall when reviewers can't see what they're approving. With BioGlyph Luma, protein engineers build multispecific and fusion formats live on a visual canvas, and leadership reviews the same design in context. It's connected to the Luma platform, and every format is registered alongside the registry or ELN you already run.

Credential your readers this month. Protect turnaround through the holidays.

A misread format rarely shows up in the design review. It shows up later, after the lab has already made it. BioGlyph Luma replaces strings of characters and tables of configuration rules with a visual design canvas, so everyone reviews the same multispecific or fusion format before work begins. Historical designs can be imported and registered alongside your existing system of record.